Condition

Advanced Gastric or Gastroesophageal Junction Adenocarcinoma clinical trials and research

• 2Clinical trials
• 1Country

All recruiting trials (2)

• ATG-022 vs investigator's choice for CLDN18.2-positive advanced gastric/GEJ cancer

  This trial tests ATG-022 against the doctor’s choice of treatment in adults whose advanced gastric or gastroesophageal junction cancer has CLDN18.2 and who have already tried at least two prior therapies.

  Recruiting Phase 3 Antengene Corporation · Bengbu, Anhui and 130 other locations · NCT07795346

• JS107 versus doctor‑chosen therapy for CLDN18.2‑positive advanced stomach or gastroesophageal junction cancer after first‑line treatment

  This trial tests whether JS107 works better than doctor‑selected chemotherapy for adults with CLDN18.2‑positive, HER2‑negative advanced stomach or gastroesophageal junction cancer who have already had at least one prior systemic therapy.

  Recruiting at 2 sites Phase 3 Shanghai Junshi Bioscience Co., Ltd. · Hefei, Anhui and 67 other locations · NCT07284134

Quick answers

How many Advanced Gastric or Gastroesophageal Junction Adenocarcinoma clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →